- Home
- ATR vs CAI Comparison
ATR vs CAI Comparison
Compare ATR & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATR
- CAI
- Stock Information
- Founded
- ATR 1992
- CAI 2008
- Country
- ATR United States
- CAI United States
- Employees
- ATR N/A
- CAI N/A
- Industry
- ATR Plastic Products
- CAI Medical Specialities
- Sector
- ATR Industrials
- CAI Health Care
- Exchange
- ATR Nasdaq
- CAI Nasdaq
- Market Cap
- ATR 9.3B
- CAI 9.4B
- IPO Year
- ATR 1993
- CAI 2025
- Fundamental
- Price
- ATR $135.16
- CAI $33.66
- Analyst Decision
- ATR Strong Buy
- CAI Strong Buy
- Analyst Count
- ATR 5
- CAI 6
- Target Price
- ATR $183.80
- CAI $35.50
- AVG Volume (30 Days)
- ATR 416.1K
- CAI 500.2K
- Earning Date
- ATR 10-23-2025
- CAI 11-12-2025
- Dividend Yield
- ATR 1.33%
- CAI N/A
- EPS Growth
- ATR 21.86
- CAI N/A
- EPS
- ATR 5.79
- CAI N/A
- Revenue
- ATR $3,610,693,000.00
- CAI $533,847,000.00
- Revenue This Year
- ATR $4.33
- CAI $64.66
- Revenue Next Year
- ATR $5.08
- CAI $45.81
- P/E Ratio
- ATR $23.31
- CAI N/A
- Revenue Growth
- ATR 1.51
- CAI 106.53
- 52 Week Low
- ATR $130.85
- CAI $25.40
- 52 Week High
- ATR $178.03
- CAI $42.50
- Technical
- Relative Strength Index (RSI)
- ATR 35.59
- CAI N/A
- Support Level
- ATR $134.85
- CAI N/A
- Resistance Level
- ATR $138.28
- CAI N/A
- Average True Range (ATR)
- ATR 2.35
- CAI 0.00
- MACD
- ATR 0.17
- CAI 0.00
- Stochastic Oscillator
- ATR 15.75
- CAI 0.00
About ATR AptarGroup Inc.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
About CAI Caris Life Sciences Inc. Common Stock
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.